Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,660.00 ILa | +0.95% |
|
+11.27% | +5.65% |
| Market Cap | 40.42B 0 35.51B 33.15B 30.42B 56.95B 3,871B 58.35B 393B 154B 1,916B 152B 148B 6,622B | P/E 2026 * |
46.6x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 52.61B 0 46.23B 43.15B 39.6B 74.13B 5,039B 75.96B 512B 200B 2,494B 198B 193B 8,620B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.83x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | +0.95% | ||
| 1 week | +11.27% | ||
| Current month | +8.37% | ||
| 1 month | +8.37% | ||
| 3 months | +2.70% | ||
| 6 months | +5.54% | ||
| Current year | +5.65% |
| 1 week | 9,450 |  | 10,760 |
| 1 month | 9,396 | | 10,760 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 3,002 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 20,860 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | +11.27% | - | - | 40.42B | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -2.28% | +1.26% | +36.33% | +30.78% | 353B | |
| -1.60% | -0.05% | +34.29% | +40.11% | 301B | |
| -2.59% | +0.71% | +11.13% | +14.23% | 271B | |
| -1.69% | +3.59% | +2.09% | -39.24% | 228B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | |
| Average | -1.35% | +4.83% | +31.33% | +52.58% | 412.19B | |
| Weighted average by Cap. | -1.61% | +4.86% | +41.22% | +77.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.57B 0 14.56B 13.59B 12.47B 23.35B 1,587B 23.92B 161B 63.02B 785B 62.21B 60.86B 2,715B | 17.29B 0 15.19B 14.18B 13.02B 24.37B 1,656B 24.97B 168B 65.77B 820B 64.92B 63.51B 2,833B |
| Net income | 1.14B 0 1B 934M 857M 1.6B 109B 1.64B 11.07B 4.33B 53.95B 4.27B 4.18B 187B | 2.36B 0 2.07B 1.93B 1.78B 3.32B 226B 3.4B 22.94B 8.97B 112B 8.85B 8.66B 386B |
| Net Debt | 12.19B 0 10.71B 10B 9.18B 17.18B 1,168B 17.6B 119B 46.37B 578B 45.77B 44.78B 1,998B | 8.45B 0 7.42B 6.93B 6.36B 11.9B 809B 12.19B 82.14B 32.12B 400B 31.71B 31.02B 1,384B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | ILA 10,660.00 | +0.95% | 958,730 |
| 29/07/26 | ILA 10,560.00 | +10.17% | 2,354,552 |
| 28/07/26 | ILA 9,585.00 | +0.89% | 831,774 |
| 27/07/26 | ILA 9,500.00 | -0.84% | 1,193,392 |
| 24/07/26 | ILA 9,580.00 | +0.49% | 1,325,339 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
